ST5 anticorps (AA 68-88) (HRP)
Aperçu rapide pour ST5 anticorps (AA 68-88) (HRP) (ABIN7140160)
Antigène
Voir toutes ST5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 68-88
-
Réactivité croisée
- Humain
-
Purification
- Antigen Affinity Purified
-
Immunogène
- Peptide sequence from Human Suppression of tumorigenicity 5 protein (68-88AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ST5 (Suppression of Tumorigenicity 5 (ST5))
-
Autre désignation
- ST5
-
Sujet
-
Background: Guanine nucleotide exchange factor (GEF) which may activate RAB9A and RAB9B. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form. May be involved in cytoskeletal organization and tumorogenicity. Isoform 1 seems to be involved in a signaling transduction pathway leading to activation of MAPK1/ERK2. Isoform 3 may block ERK2 activation stimulated by ABL1. Isoform 3 may alter cell morphology and cell growth.
Aliases: DENND2B antibody, DENN domain containing protein 2B antibody, DENN domain-containing protein 2B antibody, DENN/MADD domain containing 2B antibody, HeLa tumor suppression 1 antibody, HTS1 antibody, p126 antibody, ST 5 antibody, ST5 antibody, ST5_HUMAN antibody, Suppression of tumorigenicity 5 antibody, Suppression of tumorigenicity 5 protein antibody
-
UniProt
- P78524
Antigène
-